Research News

  • Gramling Study Finds Machine Learning Illuminates End-of-Life Conversations
    Researchers at the University of Vermont’s Vermont Conversation Lab, including Miller Chair of Palliative Medicine Robert Gramling, M.D., D.Sc., have used machine learning and natural language processing to better understand what conversations surrounding life-threatening and serious illnesses look like, in order to help healthcare providers improve their end-of-life communication. Their work was published December 9 in the journal Patient Education and Counselling.
  • Silverman & Plante's Study Finds Link between Beta Blocker Use & Hospitalizations
    A new publication by UVM Clinical Instructor in Medicine Daniel Silverman, M.D., and Assistant Professor of Medicine Timothy Plante, M.D., M.H.S., in JAMA Network Open links use of beta-blockers to heart failure hospitalizations among those with this common “stiff heart” heart failure sub-type.
  • Cushman and Copeland Named to List of World’s Most Influential Researchers
    Two University of Vermont Larner College of Medicine faculty have been named to a list of the world’s most influential researchers, based on the number of times their published studies have been cited by other researchers over the past decade. Researchers on the list are in the top 1 percent of all scholars whose work has been cited. The prestigious Highly Cited Researchers list is compiled and published annually by Clarivate Analytics.
  • Fujii Presents Postoperative Opioid Prescribing Study Results at ACS Meeting
    A study that evaluated opioid prescribing patterns at the University of Vermont Medical Center (UVMMC) before and after state-mandated regulations went into effect was presented by UVM Larner College of Medicine Clinical Instructor of Surgery Mayo Fujii, M.D., M.S., at the American College of Surgeons Clinical Congress 2019.
  • Research Excellence and Scholarship Highlighted at Annual Celebration Events
    The Larner College of Medicine's fourth annual "Celebrating Excellence in Research" series featured two days of presentations and recognition designed to highlight research performed by junior faculty, senior faculty, postdoctoral trainees, and graduate students at the College.
  • Lead Gift from Alum Firestone Brings Planned Medical Research Building Closer
    Steve Firestone, M.D.’69, has been an annual donor to the University of Vermont’s Larner College of Medicine since the 1970s, and in the early 2000s, donated artwork to help enhance the students’ learning environment. When plans began to take shape for a new biomedical research facility at the College, Firestone was inspired to step forward with his first major gift to the University. And, as over two hundred attendees learned in a ceremony held at the Larner College of Medicine earlier this month, that gift is an important one.
  • Dixon Named Director of Vermont Lung Center
    Anne Dixon, M.A., BM BCh, professor of medicine and division chief of pulmonary disease & critical care medicine at the Larner College of Medicine at the University of Vermont, has been named the new director of the Vermont Lung Center.
  • MIT Artificial Intelligence Expert Celi presented Stetson Lecture on September 11
    On Wednesday, September 11, Leo Anthony Celi, M.D., M.S., M.P.H., presented the Annual Stetson Lecture in Technological Advances in Medicine.
  • FAN Program Makes It Easy for Faculty to Cross Disciplines. And It Comes with Free Lunch
    UVM’s Faculty Activity Network, or FAN, presents a unique opportunity to find collaborators in different disciplines. The program comes with a perk: a lunch in Waterman Manor after the lab session with Richard Galbraith, M.D., Ph.D., whose only cost for participants is to weather the friendly interrogation the research vice president launches at his lunch companions.
  • Gramling's Work on Silence in End-of-Life Conversations in The Atlantic
    (AUGUST 27, 2019) A long feature story published in Mosaic and The Atlantic focuses on research led by Bob Gramling, M.D., D.Sc., Miller Chair in Palliative Medicine, and colleagues about conversations between clinicians and dying patients.